AbbVie
ABBV
#30
Rank
โ‚น25.980 T
Marketcap
โ‚น14,702
Share price
0.10%
Change (1 day)
14.93%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚น6.027 Trillion

According to AbbVie's latest financial reports the company's total debt is โ‚น6.027 Trillion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚น4.943 T-5.58%
2022-12-31โ‚น5.235 T-8.27%
2021-12-31โ‚น5.707 T-9.31%
2020-12-31โ‚น6.293 T32.26%
2019-12-31โ‚น4.758 T68.82%
2018-12-31โ‚น2.818 T18.13%
2017-12-31โ‚น2.385 T-4.7%
2016-12-31โ‚น2.503 T18.95%
2015-12-31โ‚น2.104 T121.73%
2014-12-31โ‚น949.21 B4.36%
2013-12-31โ‚น909.58 B6%
2012-12-31โ‚น858.08 B33693.67%
2011-12-31โ‚น2.53 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น5.649 T-6.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.358 T-27.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.639 T-56.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.121 T-15.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.971 T-67.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น564.00 B-90.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.822 T-69.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น2.676 T-55.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น21.31 B-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA